Personal value of Alzheimer's disease biomarker testing and result disclosure from the patient and care partner perspective

Abstract INTRODUCTION We described patients’ and care partners’ experiences with Alzheimer's disease (AD) cerebrospinal fluid (CSF) biomarker testing and result disclosure in routine care. METHODS IMPACT‐AD BC is an observational study of clinic patients who underwent AD CSF biomarker testing as par...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Khushbu J. Patel, David Yang, Howard H. Feldman, Ging‐Yuek R. Hsiung, Haakon B. Nygaard, John R. Best, Emily Dwosh, Julie M. Robillard, Mari L. DeMarco
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2024-04-01
coleção:	Alzheimer’s & Dementia: Translational Research & Clinical Interventions
Assuntos:	Alzheimer disease biomarkers caregivers cerebrospinal fluid counseling decision making
Acesso em linha:	https://doi.org/10.1002/trc2.12463
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!